Downregulation of CD151 Restricts VCAM-1 Mediated Leukocyte

Total Page:16

File Type:pdf, Size:1020Kb

Downregulation of CD151 Restricts VCAM-1 Mediated Leukocyte Gao et al. Journal of Neuroinflammation (2021) 18:118 https://doi.org/10.1186/s12974-021-02171-6 RESEARCH Open Access Downregulation of CD151 restricts VCAM-1 mediated leukocyte infiltration to reduce neurobiological injuries after experimental stroke Ceshu Gao1†, Wangyue Jia2†, Wendeng Xu1, Qiong Wu2* and Jian Wu1* Abstract Background: Translational failures in anti-adhesion molecule therapies after stroke reveal the necessity of developing new strategies that not only interrupt leukocyte recruitment but also consider the inhibition of endothelial cell inflammation, verification of therapeutic time window, and normal function maintenance of circulating leukocytes. Our study focused on the potential therapeutic value of CD151 downregulation in improving current anti-adhesion molecule therapies. Methods: Lentivirus intracerebroventricular administration was conducted to inhibit the CD151 expression and observe its functional influence on neurological injuries and outcomes. Then, immunohistochemistry and myeloperoxidase activity assessment were performed to explore the effects of CD151 expression on neutrophil and monocyte recruitment after rat cerebral ischemia. Primary rat brain microvascular endothelial cells were subjected to oxygen glucose deprivation and reoxygenationtoelucidatetheunderlyingworking mechanisms between CD151 and VCAM-1. Results: The CD151 downregulation remarkably reduced neurological injuries and improved neurological outcomes, which were accompanied with reduced neutrophil and monocyte infiltration after the CD151 downregulation. The VCAM-1 expression was remarkably decreased among the adhesion molecules on the endothelial cell responsible for neutrophil and monocyte infiltration. The activation of p38 MAPK and NF-κB pathways was restricted after the CD151 downregulation. p38 MAPK and NF-κB inhibitors decreased the VCAM-1 expression, and p38 acted as an upstream regulator of NF-κB. However, CD151 downregulation did not directly influence the neutrophil and monocyte activation. Conclusions: Overall, CD151 regulated the expression of adhesion molecules. It also played a critical role in suppressing VCAM-1-mediated neutrophil and monocyte infiltration via the p38/NF-κB pathway. This study possibly provided a new basis for improving current anti-adhesion molecule therapies. Keywords: CD151, VCAM-1, Endothelial cell, Neutrophil, Monocyte, Stroke * Correspondence: [email protected]; [email protected] †Ceshu Gao and Wangyue Jia contributed equally to this work. 2MOE Key Laboratory of Bioinformatics, School of Life Sciences, Tsinghua University, Beijing 100084, China 1Department of Neurology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing 102218, China © The Author(s). 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. Gao et al. Journal of Neuroinflammation (2021) 18:118 Page 2 of 16 Background approved by the Institutional Animal Care and Use Leukocyte infiltration after cerebral ischemia is linked to Committee at Tsinghua University. The animals were secondary injury after ischemic stroke [1]. It is also asso- placed in a house with a 12-h light/dark cycle condition, ciated with a poor prognosis in clinical trials and experi- a temperature of 23 °C ± 3 °C, a relative humidity of 50– mental animal studies [2, 3]. Neutrophils and monocytes 60%, and ad libitum access to water and chow. All the are among the major immune cells that infiltrate after rats were randomly assigned to different groups. All the cerebral ischemia and their infiltration peaks within 3 experiments followed a double-blind method. days after cerebral ischemia [4]. As the base of leukocyte infiltration, the blockade of adhesion molecules respon- Middle cerebral artery occlusion (MCAO) model in rats sible for the leukocyte-endothelial cell interaction has A rat experimental ischemic stroke model was established led to promising neurological outcomes [5]. However, as previously described [11]. After lentivirus intracerebro- anti-adhesion molecule therapies fail to meet the clinical ventricular administration and 7-day normal breeding, the needs. The translational failures of these therapies indi- weight of rats naturally increased. The adult rats (295– cate the need for the development of reliable potential 305 g) were initially anesthetized with 5% isoflurane and targets and the verification of optimal therapeutic time maintained with 2–2.5% isoflurane during surgery. The window [6]. body temperature of the rats was maintained at 37 °C ± New evidence suggests the emerging role of tetraspa- 0.5 °C by using a surface heating pad. Experimental cere- nin in the interaction of immune and endothelial cells. bral ischemia was induced by inserting a silicone-coated As a member of the tetraspanin family, CD151 is known filament (Cinontech, China) into the right common ca- as a modulator of the activities of different transmem- rotid artery to block the middle cerebral artery (MCA). brane protein families; it also functions as a partner of After 2 h MCAO, the filament was withdrawn to restore adhesion molecules during chronic inflammation [7]. the blood flow. Sham-operated rats were subjected to the CD151, CD9, VCAM-1, and ICAM-1 form tetraspanin- same procedure, but the filament was inserted into the ca- enriched microdomains (TEMs) [8]. Activated endothe- rotid artery without blocking the MCA. lial cells actually assemble preexisting TEMs to form endothelial docking structures instead of relying on the Lentivirus construction, intracerebroventricular (ICV) unstructured interaction of adhesion molecules and li- administration, and effectiveness measurement gands [9, 10]. Thus, adhesion molecules (ICAM-1, The lentivirus for expressing the CD151 shRNA (LV VCAM-1, and E-selectin) respond to ligands presented CD151 shRNA) and the scramble lentivirus with an inert by leukocytes and are regulated by CD151 on endothelial random shRNA sequence (LV Vehicle) were purchased cells in the early stage. Therefore, the involvement of from GenePharma Corporation (Shanghai, China). Both CD151 in adhesion molecule regulation enriches our un- the two lentiviruses expressed GFP tag. The lentivirus derstanding of the interaction between endothelial cells shRNA information is presented in detail in Table S1. and leukocytes and may further explain the current fail- The effectiveness of different modes of lentivirus CD151 ures in anti-adhesion molecule therapies. However, stud- shRNA transfection was confirmed through Western ies have yet to clarify whether the role of tetraspanin, blot and RT-PCR (Additional file: Figure S1). especially CD151, in TEMs is valuable enough to bridge The rats were divided into three groups, namely, lenti- the translational gap in terms of anti-adhesion molecule virus vehicle injection and sham surgery (LV Vehicle + therapies in ischemic stroke. Sham), lentivirus vehicle injection and MCAO (LV Ve- This work aimed to investigate the therapeutic value hicle + MCAO), and lentivirus CD151 shRNA injection of CD151 downregulation and its function in leukocyte and MCAO (LV CD151 shRNA + MCAO). infiltration after cerebral ischemia. Herein, we specific- The rats were transfected with the lentivirus through ally focused on the changes in the expression of TEM ICV injection 7 days before the MCAO surgery. Briefly, components and other adhesion molecules in endothe- they were anesthetized with 2% sodium pentobarbital lial cells in neutrophil and monocyte recruitment after (60–80 mg/kg) and placed in a stereotaxic apparatus experimental stroke. (Cinontech, China). The ICV injection was performed using a 10-μl syringe, and coordinates were 2 mm lateral Methods to the bregma, 1.5 mm posterior to the bregma, and 4–5 Animals mm deep from the dura. The rats received either 8 μlof A total of 239 specific pathogen-free male Sprague- LV CD151 shRNA (1 × 109 TU/ml) or 8 μl of LV vehicle Dawley rats were included, and a mortality of around 6% (1 × 109 TU/ml) at a rate of 0.5 μl/min. After 5 min, the was observed. The rats weighing 250–260 g were first needle was slowly withdrawn to prevent reflux. purchased from the Beijing Vital River Laboratory Ani- The GFP expression, which indicated successful lenti- mal Technology Co. Experimental protocols were virus infection in vivo was detected with LSM880 Gao et al. Journal of Neuroinflammation (2021) 18:118 Page 3 of 16 Airyscan (Zeiss, Germany) in the cryosections of the A forelimb placing test was carried out to assess the brain tissues 7 days after
Recommended publications
  • RI-Mediated Mast Cell Activation Ε of Fc Tetraspanin CD151 Is A
    Tetraspanin CD151 Is a Negative Regulator of Fc εRI-Mediated Mast Cell Activation Hiam Abdala-Valencia, Paul J. Bryce, Robert P. Schleimer, Joshua B. Wechsler, Lucas F. Loffredo, Joan M. Cook-Mills, This information is current as Chia-Lin Hsu and Sergejs Berdnikovs of September 26, 2021. J Immunol 2015; 195:1377-1387; Prepublished online 1 July 2015; doi: 10.4049/jimmunol.1302874 http://www.jimmunol.org/content/195/4/1377 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2015/07/01/jimmunol.130287 Material 4.DCSupplemental http://www.jimmunol.org/ References This article cites 63 articles, 28 of which you can access for free at: http://www.jimmunol.org/content/195/4/1377.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision by guest on September 26, 2021 • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2015 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Tetraspanin CD151 Is a Negative Regulator of Fc«RI-Mediated Mast Cell Activation Hiam Abdala-Valencia,* Paul J.
    [Show full text]
  • Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse
    Welcome to More Choice CD Marker Handbook For more information, please visit: Human bdbiosciences.com/eu/go/humancdmarkers Mouse bdbiosciences.com/eu/go/mousecdmarkers Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse CD3 CD3 CD (cluster of differentiation) molecules are cell surface markers T Cell CD4 CD4 useful for the identification and characterization of leukocytes. The CD CD8 CD8 nomenclature was developed and is maintained through the HLDA (Human Leukocyte Differentiation Antigens) workshop started in 1982. CD45R/B220 CD19 CD19 The goal is to provide standardization of monoclonal antibodies to B Cell CD20 CD22 (B cell activation marker) human antigens across laboratories. To characterize or “workshop” the antibodies, multiple laboratories carry out blind analyses of antibodies. These results independently validate antibody specificity. CD11c CD11c Dendritic Cell CD123 CD123 While the CD nomenclature has been developed for use with human antigens, it is applied to corresponding mouse antigens as well as antigens from other species. However, the mouse and other species NK Cell CD56 CD335 (NKp46) antibodies are not tested by HLDA. Human CD markers were reviewed by the HLDA. New CD markers Stem Cell/ CD34 CD34 were established at the HLDA9 meeting held in Barcelona in 2010. For Precursor hematopoetic stem cell only hematopoetic stem cell only additional information and CD markers please visit www.hcdm.org. Macrophage/ CD14 CD11b/ Mac-1 Monocyte CD33 Ly-71 (F4/80) CD66b Granulocyte CD66b Gr-1/Ly6G Ly6C CD41 CD41 CD61 (Integrin b3) CD61 Platelet CD9 CD62 CD62P (activated platelets) CD235a CD235a Erythrocyte Ter-119 CD146 MECA-32 CD106 CD146 Endothelial Cell CD31 CD62E (activated endothelial cells) Epithelial Cell CD236 CD326 (EPCAM1) For Research Use Only.
    [Show full text]
  • Expression of the Tetraspanins CD9, CD37, CD63, and CD151 in Merkel Cell Carcinoma: Strong Evidence for a Posttranscriptional Fine-Tuning of CD9 Gene Expression
    Modern Pathology (2010) 23, 751–762 & 2010 USCAP, Inc. All rights reserved 0893-3952/10 $32.00 751 Expression of the tetraspanins CD9, CD37, CD63, and CD151 in Merkel cell carcinoma: strong evidence for a posttranscriptional fine-tuning of CD9 gene expression Markus Woegerbauer1, Dietmar Thurnher1, Roland Houben2, Johannes Pammer3, Philipp Kloimstein1, Gregor Heiduschka1, Peter Petzelbauer4 and Boban M Erovic1 1Department of Otorhinolaryngology, Head and Neck Surgery, Medical University of Vienna, Vienna, Austria; 2Department of Dermatology, Medical University of Wuerzburg, Germany; 3Department of Clinical Pathology, Medical University of Vienna, Vienna, Austria and 4Department of Dermatology, Medical University of Vienna, Vienna, Austria Tetraspanins including CD9, CD37, CD63, and CD151 are linked to cellular adhesion, cell differentiation, migration, carcinogenesis, and tumor progression. The aim of the study was to detect, quantify, and evaluate the prognostic value of these tetraspanins in Merkel cell carcinoma and to study the regulation of CD9 mRNA expression in Merkel cell carcinoma cell lines in detail. Immunohistochemical staining of 28 Merkel cell carcinoma specimens from 25 patients showed a significant correlation of CD9 (P ¼ 0.03) and CD151 (P ¼ 0.043) expression to overall survival. CD9 and CD63 expression correlated significantly to patients’ disease-free interval (P ¼ 0.017 and P ¼ 0.058). Of primary Merkel cell carcinoma tumors, 42% were CD9 positive in contrast to only 21% of the subcutaneous in-transit metastases. Characterization of the 50 untranslated region (UTR) of the CD9 mRNA from two cultured Merkel cell carcinoma cell lines revealed the presence of two major RNA species differing only in the length of their 50 termini (183 versus 102 nucleotides).
    [Show full text]
  • Kruppel-Like Factor 9 Inhibits Glioblastoma Stemness
    KRUPPEL-LIKE FACTOR 9 INHIBITS GLIOBLASTOMA STEMNESS THROUGH GLOBAL TRANSCRIPTION REPRESSION AND INHIBITION OF INTEGRIN ALPHA 6 AND CD151 By Jessica Tilghman A dissertation submitted to Johns Hopkins University in conformity with the requirements for the degree of Doctor of Philosophy Baltimore, Maryland October, 2015 Abstract Glioblastoma (GBM) stem cells (GSCs) represent tumor-propagating cells with stem-like characteristics (stemness) that contribute disproportionately to GBM drug resistance and tumor recurrence. Understanding the mechanisms supporting GSC stemness is important for developing novel strategies that target tumor propagation to inhibit cancer progression and improve patient survival. Krüppel-like factor 9 (KLF9) has emerged as a regulator of cell differentiation, neural development, and oncogenesis; however, the molecular basis for KLF9’s diverse contextual functions has been unclear. We establish for the first time a genome-wide map of KLF9-regulated targets in human glioblastoma stem-like cells, and show that KLF9 functions as a transcriptional repressor and thereby regulates multiple signaling pathways involved in oncogenesis and regulation of cancer stem-like phenotype. A detailed analysis of two novel KLF9 targets suggests that KLF9 inhibits glioma cell stemness by repressing expression of integrin α6 and CD151. The expression of one candidate KLF9 target gene ITGA6 coding for integrin α6 was verified to be downregulated by KLF9 in GSCs. ITGA6 transcription repression by KLF9 altered GBM neurosphere cell behavior as evidenced by reduced cell adhesion to and migration through membrane coated with the integrin α6 ligand laminin. Forced expression of integrin α6 partially rescued GBM neurosphere cells from the differentiating and adhesion/migration-inhibiting effects of KLF9.
    [Show full text]
  • Human Eosinophils and Their Activation by Allergens Via Danger
    Human eosinophils and their activation by allergens via danger signal receptors Elin Redvall ______________________ 2010 Department of Infectious diseases, Institute of Biomedicine, The Sahlgrenska Academy Cover illustration photo: Kerstin Andersson (Eosinophils) Abstract Human eosinophilic granulocytes are polymorphonuclear cells with a powerful arsenal of cytotoxic substances in their granules, which are mainly found in the gastrointestinal mucosa, and the respiratory and genitourinary tracts. Their physiological role is incompletely understood, although it is likely they protect the mucosal surfaces, perhaps by recognizing danger signals present on microorganisms or released from damaged tissue. We have earlier shown that eosinophils can recognize and become directly activated by aeroallergens such as house dust mite (HDM) and birch pollen. Eosinophils exposed to (HDM) release both of the cytotoxic granule proteins eosinophil peroxidase (EPO) and major basic protein, whereas birch pollen extract only triggers EPO release. Here we further investigate which receptors on eosinophils are used to signal the presence of HDM and birch pollen. Recognition was found to be mediated by the formyl peptide receptors (FPRs) FPR1 and FPR2. We also characterized the expression of this family of receptors in human eosinophils and found that they express FPR1 and FPR2, but not FPR3, similar to neutrophilic granulocytes. We also discovered that signaling through FPR1 can desensitize the eotaxin-1 receptor CCR3 rendering the cells anergic with respect to chemotaxis in response to eotaxin-1, but not regarding respiratory burst. Hence, there is cross- talk between these two receptors regarding one important effector function of eosinophils. Eosinophilic reactivity in vitro to the aeroallergens HDM, birch pollen, timothy grass pollen and cat dander did not differ between individuals with allergy and healthy individuals.
    [Show full text]
  • Tetraspanin CD151 Plays a Key Role in Skin Squamous Cell Carcinoma
    Oncogene (2013) 32, 1772–1783 & 2013 Macmillan Publishers Limited All rights reserved 0950-9232/13 www.nature.com/onc ORIGINAL ARTICLE Tetraspanin CD151 plays a key role in skin squamous cell carcinoma QLi1, XH Yang2,FXu1, C Sharma1, H-X Wang1, K Knoblich1, I Rabinovitz3, SR Granter4 and ME Hemler1 Here we provide the first evidence that tetraspanin CD151 can support de novo carcinogenesis. During two-stage mouse skin chemical carcinogenesis, CD151 reduces tumor lag time and increases incidence, multiplicity, size and progression to malignant squamous cell carcinoma (SCC), while supporting both cell survival during tumor initiation and cell proliferation during the promotion phase. In human skin SCC, CD151 expression is selectively elevated compared with other skin cancer types. CD151 support of keratinocyte survival and proliferation may depend on activation of transcription factor STAT3 (signal transducers and activators of transcription), a regulator of cell proliferation and apoptosis. CD151 also supports protein kinase C (PKC)a–a6b4 integrin association and PKC-dependent b4 S1424 phosphorylation, while regulating a6b4 distribution. CD151–PKCa effects on integrin b4 phosphorylation and subcellular localization are consistent with epithelial disruption to a less polarized, more invasive state. CD151 ablation, while minimally affecting normal cell and normal mouse functions, markedly sensitized mouse skin and epidermoid cells to chemicals/drugs including 7,12-dimethylbenz[a]anthracene (mutagen) and camptothecin (topoisomerase inhibitor), as well as to agents targeting epidermal growth factor receptor, PKC, Jak2/Tyk2 and STAT3. Hence, CD151 ‘co-targeting’ may be therapeutically beneficial. These findings not only support CD151 as a potential tumor target, but also should apply to other cancers utilizing CD151/laminin-binding integrin complexes.
    [Show full text]
  • Aberrant Expression of Tetraspanin Molecules in B-Cell Chronic Lymphoproliferative Disorders and Its Correlation with Normal B-Cell Maturation
    Leukemia (2005) 19, 1376–1383 & 2005 Nature Publishing Group All rights reserved 0887-6924/05 $30.00 www.nature.com/leu Aberrant expression of tetraspanin molecules in B-cell chronic lymphoproliferative disorders and its correlation with normal B-cell maturation S Barrena1,2, J Almeida1,2, M Yunta1,ALo´pez1,2, N Ferna´ndez-Mosteirı´n3, M Giralt3, M Romero4, L Perdiguer5, M Delgado1, A Orfao1,2 and PA Lazo1 1Instituto de Biologı´a Molecular y Celular del Ca´ncer, Centro de Investigacio´n del Ca´ncer, Consejo Superior de Investigaciones Cientı´ficas-Universidad de Salamanca, Salamanca, Spain; 2Servicio de Citometrı´a, Universidad de Salamanca and Hospital Universitario de Salamanca, Salamanca, Spain; 3Servicio de Hematologı´a, Hospital Universitario Miguel Servet, Zaragoza, Spain; 4Hematologı´a-hemoterapia, Hospital Universitario Rı´o Hortega, Valladolid, Spain; and 5Servicio de Hematologı´a, Hospital de Alcan˜iz, Teruel, Spain Tetraspanin proteins form signaling complexes between them On the cell surface, tetraspanin antigens are present either as and with other membrane proteins and modulate cell adhesion free molecules or through interaction with other proteins.25,26 and migration properties. The surface expression of several tetraspanin antigens (CD9, CD37, CD53, CD63, and CD81), and These interacting proteins include other tetraspanins, integri- F 22,27–30F their interacting proteins (CD19, CD21, and HLA-DR) were ns particularly those with the b1 subunit HLA class II 31–33 34,35 analyzed during normal B-cell maturation and compared to a moleculesFeg HLA DR -, CD19, the T-cell recep- group of 67 B-cell neoplasias. Three patterns of tetraspanin tor36,37 and several other members of the immunoglobulin expression were identified in normal B cells.
    [Show full text]
  • CD151-Α3β1 Integrin Complexes Are Prognostic Markers of Glioblastoma and Cooperate with EGFR to Drive Tumor Cell Motility and Invasion
    CD151-α3β1 integrin complexes are prognostic markers of glioblastoma and cooperate with EGFR to drive tumor cell motility and invasion The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Zhou, P., S. Erfani, Z. Liu, C. Jia, Y. Chen, B. Xu, X. Deng, et al. 2015. “CD151-α3β1 integrin complexes are prognostic markers of glioblastoma and cooperate with EGFR to drive tumor cell motility and invasion.” Oncotarget 6 (30): 29675-29693. Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:25658316 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA www.impactjournals.com/oncotarget/ Oncotarget, Vol. 6, No. 30 CD151-α3β1 integrin complexes are prognostic markers of glioblastoma and cooperate with EGFR to drive tumor cell motility and invasion Pengcheng Zhou1,*, Sonia Erfani2,*, Zeyi Liu2,3,*, Changhe Jia2,4,*, Yecang Chen5,*, Bingwei Xu2, Xinyu Deng2, Jose E. Alfáro1, Li Chen2, Dana Napier6, Michael Lu8, Jian-An Huang3, Chunming Liu7, Olivier Thibault2, Rosalind Segal1, Binhua P. Zhou7, Natasha Kyprianou9, Craig Horbinski6,#, Xiuwei H. Yang2,# 1DepartmentofCancerBiologyandPediatricOncology,Dana-FarberCancerInstituteandHarvardMedicalSchool,Boston, MA,USA 2Department of Pharmacology and Nutritional Sciences, Markey Cancer Center and University of Kentucky,
    [Show full text]
  • Lack of CD151/Integrin Alpha 3 Beta 1
    This is a repository copy of Lack of CD151/integrin alpha 3 beta 1 complex is predictive of poor outcome in node-negative lobular breast carcinoma: opposing roles of CD151 in invasive lobular and ductal breast cancers. White Rose Research Online URL for this paper: http://eprints.whiterose.ac.uk/94410/ Version: Accepted Version Article: Romanska, HM, Potemski, P, Krakowska, M et al. (8 more authors) (2015) Lack of CD151/integrin alpha 3 beta 1 complex is predictive of poor outcome in node-negative lobular breast carcinoma: opposing roles of CD151 in invasive lobular and ductal breast cancers. British Journal of Cancer, 113 (9). pp. 1350-1357. ISSN 0007-0920 https://doi.org/10.1038/bjc.2015.344 Reuse Unless indicated otherwise, fulltext items are protected by copyright with all rights reserved. The copyright exception in section 29 of the Copyright, Designs and Patents Act 1988 allows the making of a single copy solely for the purpose of non-commercial research or private study within the limits of fair dealing. The publisher or other rights-holder may allow further reproduction and re-use of this version - refer to the White Rose Research Online record for this item. Where records identify the publisher as the copyright holder, users can verify any specific terms of use on the publisher’s website. Takedown If you consider content in White Rose Research Online to be in breach of UK law, please notify us by emailing [email protected] including the URL of the record and the reason for the withdrawal request. [email protected] https://eprints.whiterose.ac.uk/ Lack of CD151/integrin complex is predictive of poor outcome in node–negative lobular breast carcinoma: opposing roles of CD151 in invasive lobular and ductal breast cancers.
    [Show full text]
  • Original Article Integrin-Associated CD151 Is a Suppressor of Prostate Cancer Progression
    Am J Transl Res 2020;12(4):1428-1442 www.ajtr.org /ISSN:1943-8141/AJTR0108465 Original Article Integrin-associated CD151 is a suppressor of prostate cancer progression Rongbo Han1,2*, Patrick J Hensley3*, Jieming Li2,4, Yang Zhang2,5, Timothy W Stark3, Allie Heller2, Hai Qian4, Junfeng Shi1, Zeyi Liu5, Jian-An Huang5, Tengchuan Jin6, Xiaowei Wei1, Binhua P Zhou2, Yadi Wu2, Natasha Kyprianou3, Jinfei Chen7, Xiuwei H Yang2 1Department of Oncology, Nanjing First Hospital, Nanjing, Jiangsu, P. R. China; 2Department of Pharmacology and Nutritional Sciences, Department of Molecular and Cellular Biochemistry, and Markey Cancer Center, University of Kentucky, Lexington 40536, KY, USA; 3Department of Urology, University of Kentucky College of Medicine, Lexington 40536, KY, USA; 4Center of Drug Discovery, China Pharmaceutical University, Nanjing, Jiangsu, P. R. China; 5Department of Respiratory Medicine, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, P. R. China; 6Laboratory of Structural Immunology, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, P.R. China; 7Cancer Center, Taikang Xianlin Drum Tower Hospital, Nanjing University School of Medicine, and Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, Jiangsu, P. R. China. *Equal contributors. Received January 29, 2020; Accepted March 27, 2020; Epub April 15, 2020; Published April 30, 2020 Abstract: Owing to the complexity of interacting molecular networks on the cell surface, integrin-associated tetraspanin CD151 remains controversial regarding its clinical importance and functional impact in prostate cancer. The current study evaluated dynamics and clinical importance of CD151 expression and its function in prostate cancer by IHC analysis of two independent patient cohorts (n=80, 181), bioinformatic interrogation of the TCGA da- tabase, and evaluation of gene knockdown effect at the cellular level.
    [Show full text]
  • Fibronectin Leukemia Virus Type 1-Infected T Cells to Regulates
    SFA-1/PETA-3 (CD151), a Member of the Transmembrane 4 a b Superfamily, Associates Preferentially with 5 1 Integrin and Regulates Adhesion of Human T Cell Leukemia Virus Type 1-Infected T Cells to Fibronectin1 Hitoshi Hasegawa,2 Tetsuhiko Nomura, Kyoko Kishimoto, Kohsuke Yanagisawa, and Shigeru Fujita In this study we have analyzed the adhesion molecules associated with and the biologic function of SFA-1/PETA-3 (CD151) in human T cell leukemia virus type 1 (HTLV-1)-infected T cells and in freshly isolated adult T cell leukemia (ATL) cells using an anti-CD151 a b a mAb. The anti-CD151 mAb coprecipitated 5 1 integrin from HTLV-1-infected T cells. Conversely, an anti- 5 integrin mAb copre- cipitated CD151. The anti-CD151 mAb inhibited the adhesion of HTLV-1-infected T cells to fibronectin but did not have any effect on their adhesion to laminin, collagen type I, or collagen type IV. Moreover, antisense CD151 oligonucleotide-treated HTLV-1-infected T cells showed significant inhibition of adhesion to fibronectin. These findings showed that the CD151 molecule was associated with the a b a b 5 1 integrin molecule and that it enhanced 5 1 integrin-mediated adhesion to fibronectin. In addition, the expression levels of CD151, a b a b 4 1 integrin, and 5 1 integrin on ATL cells from lymph nodes of lymphoma-type ATL patients were significantly higher than those on circulating ATL cells from leukemia-type ATL patients. This suggests that the increased expression of these integrins may contribute to lymphoma formation through the adhesion of ATL cells to the extracellular matrix and dendritic cells, rather than contributing to transmigration.
    [Show full text]
  • Human CD Marker Chart Reviewed by HLDA1 Bdbiosciences.Com/Cdmarkers
    BD Biosciences Human CD Marker Chart Reviewed by HLDA1 bdbiosciences.com/cdmarkers 23-12399-01 CD Alternative Name Ligands & Associated Molecules T Cell B Cell Dendritic Cell NK Cell Stem Cell/Precursor Macrophage/Monocyte Granulocyte Platelet Erythrocyte Endothelial Cell Epithelial Cell CD Alternative Name Ligands & Associated Molecules T Cell B Cell Dendritic Cell NK Cell Stem Cell/Precursor Macrophage/Monocyte Granulocyte Platelet Erythrocyte Endothelial Cell Epithelial Cell CD Alternative Name Ligands & Associated Molecules T Cell B Cell Dendritic Cell NK Cell Stem Cell/Precursor Macrophage/Monocyte Granulocyte Platelet Erythrocyte Endothelial Cell Epithelial Cell CD1a R4, T6, Leu6, HTA1 b-2-Microglobulin, CD74 + + + – + – – – CD93 C1QR1,C1qRP, MXRA4, C1qR(P), Dj737e23.1, GR11 – – – – – + + – – + – CD220 Insulin receptor (INSR), IR Insulin, IGF-2 + + + + + + + + + Insulin-like growth factor 1 receptor (IGF1R), IGF-1R, type I IGF receptor (IGF-IR), CD1b R1, T6m Leu6 b-2-Microglobulin + + + – + – – – CD94 KLRD1, Kp43 HLA class I, NKG2-A, p39 + – + – – – – – – CD221 Insulin-like growth factor 1 (IGF-I), IGF-II, Insulin JTK13 + + + + + + + + + CD1c M241, R7, T6, Leu6, BDCA1 b-2-Microglobulin + + + – + – – – CD178, FASLG, APO-1, FAS, TNFRSF6, CD95L, APT1LG1, APT1, FAS1, FASTM, CD95 CD178 (Fas ligand) + + + + + – – IGF-II, TGF-b latency-associated peptide (LAP), Proliferin, Prorenin, Plasminogen, ALPS1A, TNFSF6, FASL Cation-independent mannose-6-phosphate receptor (M6P-R, CIM6PR, CIMPR, CI- CD1d R3G1, R3 b-2-Microglobulin, MHC II CD222 Leukemia
    [Show full text]